Clinical Trial Update: Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combined use of oxytocin and misoprostol to prevent postpartum hemorrhage was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hemorrhage; Complicating Delivery | Phase 4 | Status: TERMINATED